
Veterinary Oncology
Description
Global Veterinary Oncology Market to Reach US$727.8 Million by 2030
The global market for Veterinary Oncology estimated at US$391.4 Million in the year 2024, is expected to reach US$727.8 Million by 2030, growing at a CAGR of 10.9% over the analysis period 2024-2030. Chemotherapy, one of the segments analyzed in the report, is expected to record a 12.0% CAGR and reach US$246.0 Million by the end of the analysis period. Growth in the Radiology segment is estimated at 9.6% CAGR over the analysis period.
The U.S. Market is Estimated at US$100.7 Million While China is Forecast to Grow at 14.3% CAGR
The Veterinary Oncology market in the U.S. is estimated at US$100.7 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$168.0 Million by the year 2030 trailing a CAGR of 14.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 9.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.5% CAGR.
Global Veterinary Oncology Market - Key Trends & Drivers Summarized
What Is Veterinary Oncology, and Why Is It So Crucial in Animal Healthcare?
Veterinary Oncology is a specialized field of veterinary medicine focused on diagnosing, treating, and managing cancer in animals. It encompasses various treatment modalities such as chemotherapy, radiation therapy, immunotherapy, surgery, and targeted therapy, designed to treat different types of cancers, including lymphomas, mast cell tumors, osteosarcomas, and melanomas in pets, livestock, and even exotic animals. Veterinary oncology aims to extend the lifespan of animals, alleviate pain, and improve the quality of life for cancer patients through early diagnosis, advanced treatment options, and ongoing care.
The importance of veterinary oncology lies in its ability to provide comprehensive cancer care for animals, addressing an increasing prevalence of cancer among companion animals such as dogs and cats, as well as livestock and wildlife. As pets are living longer due to improved healthcare, nutrition, and living conditions, age-related conditions like cancer have become more common. Veterinary oncology offers specialized diagnostic tools, personalized treatment plans, and palliative care, helping pet owners manage complex cancer cases more effectively. With growing awareness of animal welfare and the emotional bond between pet owners and their animals, veterinary oncology has become a vital component of modern veterinary medicine, aligning with broader trends toward more advanced and compassionate care for animals.
How Are Technological Advancements Shaping the Veterinary Oncology Market?
Technological advancements have significantly enhanced the diagnostic, therapeutic, and palliative capabilities of Veterinary Oncology, driving innovation across the field. One of the major developments is the rise of advanced diagnostic imaging technologies, such as computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), and ultrasound. These imaging modalities provide detailed insights into tumor size, location, and progression, enabling veterinarians to accurately diagnose cancer, plan treatments, and monitor responses. Imaging-guided biopsies and surgeries have also improved precision, minimizing tissue damage and increasing the likelihood of successful tumor removal.
Advancements in targeted therapies and immunotherapies have transformed veterinary oncology, offering new options for treating cancers in animals. Targeted therapies use drugs designed to attack specific cancer cells without affecting healthy tissues, improving efficacy and reducing side effects. Tyrosine kinase inhibitors (TKIs) and monoclonal antibodies are examples of targeted treatments that are increasingly being used in veterinary oncology, especially for conditions like mast cell tumors and lymphomas. Immunotherapies, which stimulate the animal’s immune system to recognize and destroy cancer cells, are also emerging as promising treatments for various types of tumors in animals. Vaccines, such as the melanoma vaccine for dogs, represent a significant breakthrough in using immunotherapy to manage aggressive cancers.
The adoption of precision medicine, including genetic testing and molecular diagnostics, has enabled veterinarians to develop more personalized treatment plans. By analyzing the genetic makeup of tumors, veterinary oncologists can identify specific mutations that guide treatment decisions, increasing the effectiveness of therapies and improving survival rates. The integration of radiation therapy has also advanced, with the use of stereotactic radiation therapy (SRT) and intensity-modulated radiation therapy (IMRT), offering high-dose, targeted treatments that minimize damage to surrounding healthy tissues. These technological innovations not only expand the treatment options available in veterinary oncology but also align with broader trends toward more personalized, precise, and effective cancer care for animals.
What Are the Emerging Applications of Veterinary Oncology Across Different Animal Types?
Veterinary Oncology is finding expanding applications across a variety of animal species, driven by the need for specialized cancer care in both companion and non-companion animals. In companion animals, such as dogs and cats, oncology treatments are commonly used for lymphomas, mast cell tumors, osteosarcomas, and mammary gland tumors. Chemotherapy remains a widely used treatment option, often in combination with surgery or radiation therapy, depending on the type and stage of the cancer. The use of less invasive surgical techniques, such as laparoscopic tumor removal, has also increased in treating small animals, offering quicker recovery times and improved outcomes.
In large animals, including horses and livestock, veterinary oncology is applied to manage conditions such as squamous cell carcinoma, sarcoids, and lymphoma. While the treatment options may differ due to anatomical and physiological variations, advanced therapies like radiation and cryosurgery are employed to treat tumors in horses, improving survival rates and quality of life. Chemotherapy protocols tailored for large animals, combined with supportive care, are also part of veterinary oncology practice for managing certain types of cancers in livestock, particularly those affecting valuable breeding animals.
In exotic animals and wildlife, veterinary oncology has become essential for managing cancers in zoo animals, birds, reptiles, and other species under human care. These animals present unique challenges in cancer treatment due to differences in anatomy, behavior, and immune response, requiring specialized diagnostic and therapeutic approaches. For example, innovative approaches like electrochemotherapy (a combination of chemotherapy and electrical pulses) are used to treat tumors in small mammals and exotic pets, offering an effective and minimally invasive option. The expanding applications of veterinary oncology across diverse animal types underscore its critical role in advancing animal healthcare and improving outcomes for animals with cancer.
What Drives Growth in the Veterinary Oncology Market?
The growth in the Veterinary Oncology market is driven by several factors, including increasing pet ownership, rising awareness of pet health, and advancements in cancer treatment technologies. One of the primary growth drivers is the global rise in pet ownership, with more households viewing pets as family members and seeking advanced healthcare options for them. As the average lifespan of pets increases, the incidence of cancer among companion animals has also risen, creating greater demand for specialized oncology services. Pet owners’ willingness to invest in comprehensive cancer care, including diagnostics, treatment, and palliative support, has fueled the demand for veterinary oncology services.
The growing awareness of cancer symptoms and the availability of advanced diagnostic tools have also contributed to market growth. Veterinarians are now able to detect cancers earlier, allowing for more effective treatment plans and better prognoses. The increasing number of veterinary clinics and hospitals offering specialized oncology services, coupled with the rise of veterinary referral centers, has improved access to cancer care for pets. Additionally, the use of telemedicine in veterinary oncology has expanded the reach of expert oncologists, enabling remote consultations, treatment planning, and follow-up care, which enhances access to specialized treatments in underserved areas.
Technological advancements, including targeted therapies, precision medicine, and minimally invasive procedures, have significantly expanded the treatment options available in veterinary oncology, improving success rates and reducing side effects. Regulatory support and funding for veterinary cancer research have also contributed to the development of new drugs and treatments, driving innovation in the field. As the demand for high-quality animal healthcare continues to grow, the Veterinary Oncology market is poised for robust expansion, supported by global trends toward better pet health, increasing awareness of cancer treatments, and a growing focus on personalized care for animals with cancer.
SCOPE OF STUDY:The report analyzes the Veterinary Oncology market in terms of units by the following Segments, and Geographic Regions/Countries:
Segments:
Therapy (Chemotherapy, Radiology, Immunotherapy, Surgery, Other Therapies); Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer, Other Cancer Types); Animal Type (Canine, Feline)
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Select Competitors (Total 42 Featured) -
- Accuray, Inc.
- Boehringer Ingelheim International GmbH
- Elanco Animal Health
- Elekta AB
- Karyopharm Therapeutics, Inc.
- Merck Animal Health
- Torigen Pharmaceuticals
- Varian
- Virbac SA
- Vivesto AB
We`re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.
Table of Contents
- I. METHODOLOGY
- II. EXECUTIVE SUMMARY
- 1. MARKET OVERVIEW
- Influencer Market Insights
- Tariff Impact on Global Supply Chain Patterns
- Global Economic Update
- Veterinary Oncology – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
- 2. FOCUS ON SELECT PLAYERS
- 3. MARKET TRENDS & DRIVERS
- Rising Incidence of Cancer in Animals Drives Veterinary Oncology Market
- Expanding Use of Chemotherapy Sets the Stage for Oncology Market Expansion
- Case Overview: Demand for Immunotherapy Enhances Veterinary Oncology Market
- Innovations in Tumor-Specific Diagnostics Generate New Opportunities
- Growing Use of Radiation Therapy Sustains Veterinary Oncology Demand
- Push for Early Cancer Detection Drives Oncology Market
- Expanding Use of Monoclonal Antibodies Drives Veterinary Oncology Demand
- Focus on Quality of Life in Pets Bodes Well for Veterinary Oncology
- Innovations in Drug Delivery Systems Propel Veterinary Oncology Market
- Increasing Use of Biomarkers in Diagnosis Drives Oncology Demand
- 4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 2: World Historic Review for Veterinary Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 3: World 15-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 5: World Historic Review for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 6: World 15-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 8: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 9: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 11: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 12: World 15-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 13: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 14: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 15: World 15-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 16: World Recent Past, Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 17: World Historic Review for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 18: World 15-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 19: World Recent Past, Current & Future Analysis for Canine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 20: World Historic Review for Canine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 21: World 15-Year Perspective for Canine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 22: World Recent Past, Current & Future Analysis for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 23: World Historic Review for Feline by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 24: World 15-Year Perspective for Feline by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 25: World Recent Past, Current & Future Analysis for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 26: World Historic Review for Lymphoma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 27: World 15-Year Perspective for Lymphoma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 28: World Recent Past, Current & Future Analysis for Mast Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 29: World Historic Review for Mast Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 30: World 15-Year Perspective for Mast Cell Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 31: World Recent Past, Current & Future Analysis for Mammary & Squamous Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 32: World Historic Review for Mammary & Squamous Cell Cancer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 33: World 15-Year Perspective for Mammary & Squamous Cell Cancer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 34: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 35: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 36: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
- TABLE 37: World Veterinary Oncology Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
- III. MARKET ANALYSIS
- UNITED STATES
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
- TABLE 38: USA Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 39: USA Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 40: USA 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 41: USA Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 42: USA Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 43: USA 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 44: USA Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 45: USA Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 46: USA 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- CANADA
- TABLE 47: Canada Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 48: Canada Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 49: Canada 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 50: Canada Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 51: Canada Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 52: Canada 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 53: Canada Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 54: Canada Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 55: Canada 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- JAPAN
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
- TABLE 56: Japan Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 57: Japan Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 58: Japan 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 59: Japan Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 60: Japan Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 61: Japan 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 62: Japan Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 63: Japan Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 64: Japan 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- CHINA
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
- TABLE 65: China Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 66: China Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 67: China 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 68: China Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 69: China Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 70: China 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 71: China Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 72: China Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 73: China 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- EUROPE
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
- TABLE 74: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 75: Europe Historic Review for Veterinary Oncology by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 76: Europe 15-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
- TABLE 77: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 78: Europe Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 79: Europe 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 80: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 81: Europe Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 82: Europe 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 83: Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 84: Europe Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 85: Europe 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- FRANCE
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
- TABLE 86: France Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 87: France Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 88: France 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 89: France Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 90: France Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 91: France 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 92: France Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 93: France Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 94: France 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- GERMANY
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
- TABLE 95: Germany Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 96: Germany Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 97: Germany 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 98: Germany Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 99: Germany Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 100: Germany 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 101: Germany Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 102: Germany Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 103: Germany 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- ITALY
- TABLE 104: Italy Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 105: Italy Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 106: Italy 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 107: Italy Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 108: Italy Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 109: Italy 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 110: Italy Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 111: Italy Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 112: Italy 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- UNITED KINGDOM
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
- TABLE 113: UK Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 114: UK Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 115: UK 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 116: UK Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 117: UK Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 118: UK 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 119: UK Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 120: UK Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 121: UK 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- SPAIN
- TABLE 122: Spain Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 123: Spain Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 124: Spain 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 125: Spain Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 126: Spain Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 127: Spain 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 128: Spain Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 129: Spain Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 130: Spain 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- RUSSIA
- TABLE 131: Russia Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 132: Russia Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 133: Russia 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 134: Russia Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 135: Russia Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 136: Russia 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 137: Russia Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 138: Russia Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 139: Russia 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- REST OF EUROPE
- TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 141: Rest of Europe Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 142: Rest of Europe 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 144: Rest of Europe Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 145: Rest of Europe 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 147: Rest of Europe Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 148: Rest of Europe 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- ASIA-PACIFIC
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
- TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 150: Asia-Pacific Historic Review for Veterinary Oncology by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 151: Asia-Pacific 15-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
- TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 153: Asia-Pacific Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 154: Asia-Pacific 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 156: Asia-Pacific Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 157: Asia-Pacific 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 159: Asia-Pacific Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 160: Asia-Pacific 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- AUSTRALIA
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
- TABLE 161: Australia Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 162: Australia Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 163: Australia 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 164: Australia Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 165: Australia Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 166: Australia 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 167: Australia Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 168: Australia Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 169: Australia 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- INDIA
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
- TABLE 170: India Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 171: India Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 172: India 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 173: India Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 174: India Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 175: India 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 176: India Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 177: India Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 178: India 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- SOUTH KOREA
- TABLE 179: South Korea Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 180: South Korea Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 181: South Korea 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 182: South Korea Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 183: South Korea Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 184: South Korea 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 185: South Korea Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 186: South Korea Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 187: South Korea 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- REST OF ASIA-PACIFIC
- TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 189: Rest of Asia-Pacific Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 192: Rest of Asia-Pacific Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 195: Rest of Asia-Pacific Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- LATIN AMERICA
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
- TABLE 197: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 198: Latin America Historic Review for Veterinary Oncology by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 199: Latin America 15-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
- TABLE 200: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 201: Latin America Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 202: Latin America 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 203: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 204: Latin America Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 205: Latin America 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 206: Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 207: Latin America Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 208: Latin America 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- ARGENTINA
- TABLE 209: Argentina Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 210: Argentina Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 211: Argentina 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 212: Argentina Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 213: Argentina Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 214: Argentina 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 215: Argentina Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 216: Argentina Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 217: Argentina 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- BRAZIL
- TABLE 218: Brazil Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 219: Brazil Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 220: Brazil 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 221: Brazil Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 222: Brazil Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 223: Brazil 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 224: Brazil Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 225: Brazil Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 226: Brazil 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- MEXICO
- TABLE 227: Mexico Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 228: Mexico Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 229: Mexico 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 230: Mexico Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 231: Mexico Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 232: Mexico 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 233: Mexico Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 234: Mexico Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 235: Mexico 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- REST OF LATIN AMERICA
- TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 237: Rest of Latin America Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 238: Rest of Latin America 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 240: Rest of Latin America Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 241: Rest of Latin America 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 243: Rest of Latin America Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 244: Rest of Latin America 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- MIDDLE EAST
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
- TABLE 245: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
- TABLE 246: Middle East Historic Review for Veterinary Oncology by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 247: Middle East 15-Year Perspective for Veterinary Oncology by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
- TABLE 248: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 249: Middle East Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 250: Middle East 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 251: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 252: Middle East Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 253: Middle East 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 254: Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 255: Middle East Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 256: Middle East 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- IRAN
- TABLE 257: Iran Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 258: Iran Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 259: Iran 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 260: Iran Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 261: Iran Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 262: Iran 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 263: Iran Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 264: Iran Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 265: Iran 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- ISRAEL
- TABLE 266: Israel Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 267: Israel Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 268: Israel 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 269: Israel Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 270: Israel Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 271: Israel 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 272: Israel Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 273: Israel Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 274: Israel 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- SAUDI ARABIA
- TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 276: Saudi Arabia Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 277: Saudi Arabia 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 279: Saudi Arabia Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 280: Saudi Arabia 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 282: Saudi Arabia Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 283: Saudi Arabia 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- UNITED ARAB EMIRATES
- TABLE 284: UAE Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 285: UAE Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 286: UAE 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 287: UAE Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 288: UAE Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 289: UAE 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 290: UAE Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 291: UAE Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 292: UAE 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- REST OF MIDDLE EAST
- TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 294: Rest of Middle East Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 295: Rest of Middle East 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 297: Rest of Middle East Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 298: Rest of Middle East 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 300: Rest of Middle East Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 301: Rest of Middle East 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- AFRICA
- Veterinary Oncology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
- TABLE 302: Africa Recent Past, Current & Future Analysis for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 303: Africa Historic Review for Veterinary Oncology by Therapy - Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 304: Africa 15-Year Perspective for Veterinary Oncology by Therapy - Percentage Breakdown of Value Sales for Chemotherapy, Radiology, Immunotherapy, Surgery and Other Therapies for the Years 2015, 2025 & 2030
- TABLE 305: Africa Recent Past, Current & Future Analysis for Veterinary Oncology by Animal Type - Canine and Feline - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 306: Africa Historic Review for Veterinary Oncology by Animal Type - Canine and Feline Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 307: Africa 15-Year Perspective for Veterinary Oncology by Animal Type - Percentage Breakdown of Value Sales for Canine and Feline for the Years 2015, 2025 & 2030
- TABLE 308: Africa Recent Past, Current & Future Analysis for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
- TABLE 309: Africa Historic Review for Veterinary Oncology by Cancer Type - Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
- TABLE 310: Africa 15-Year Perspective for Veterinary Oncology by Cancer Type - Percentage Breakdown of Value Sales for Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Other Cancer Types for the Years 2015, 2025 & 2030
- IV. COMPETITION
Pricing
Currency Rates